BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Respiratory Journal

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.02.01762002PMID 12358323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension

  2001cited by this paper
• BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

  2001cited by this paper
• Extracellular matrix remodeling: multiple paradigms in vascular disease.

  2001cited by this paper
• Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins

  2001cited by this paper
• Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

  2000cited by this paper
• Controlling TGF- b signaling

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

  2000influential reference
• Controlling TGF-beta signaling.

  2000cited by this paper
• Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

  2000cited by this paper
• Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.

  2000cited by this paper
• Controlling TGF-β signaling

  2000cited by this paper
• Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension

  1999cited by this paper
• Primary pulmonary hypertension associated with the use of fenfluramine derivatives.

  1998cited by this paper
• Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

  1998cited by this paper
• Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.

  1998cited by this paper
• Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32

  1997cited by this paper
• A new role for an old molecule: serotonin as a mitogen.

  1997cited by this paper
• Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.

  1997cited by this paper
• Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography.

  1997cited by this paper
• Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32.

  1997cited by this paper
• Valvular heart disease associated with fenfluramine-phentermine.

  1997cited by this paper
• Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.

  1996cited by this paper
• Carcinoid Heart Disease: Correlation of High Serotonin Levels with Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography

  1996cited by this paper
• Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

  1996cited by this paper
• Increased plasma serotonin in primary pulmonary hypertension.

  1995cited by this paper
• Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

  1995cited by this paper
• Primary pulmonary hypertension.

  1993cited by this paper
• Simultaneous Effects of p‐Chloroamphetamine, d‐Fenfluramine, and Reserpine on Free and Stored 5‐Hydroxytryptamine in Brain and Blood

  1992cited by this paper
• Dexfenfluramine

  1992cited by this paper
• Dexfenfluramine Review of its Pharmacological Properties and Therapeutic Potential in Obesity

  1992cited by this paper
• Primary pulmonary hypertension.

  1987cited by this paper
• Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?

  1979cited by this paper
• Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?

  1979cited by this paper
• Letter to the editor

  1967cited by this paper

• Pulmonary Arterial Hypertension Onset in an Adult Woman With a TBX4 Likely Pathogenic Variant Following Imatinib Administration: A Case Report

  2025cites this paper
• Response.

  2025cites this paper
• Detection and Evaluation of Drug-associated Pulmonary Arterial Hypertension.

  2025cites this paper
• Pulmonary arterial hypertension associated with exposure to toxic rapeseed oil

  2025cites this paper
• Systemic juvenile idiopathic arthritis–associated lung disease: A retrospective cohort study

  2024cites this paper
• [Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement on behalf of the International Consortium for Genetic Studies in PAH - French version].

  2023cites this paper
• Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)

  2023cites this paper
• Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension.

  2022cites this paper
• Gender differences in genotypic distribution of endothelin-1 gene and endothelin receptor A gene in pulmonary hypertension associated with rheumatic mitral valve disease

  2022cites this paper
• Drug-induced pulmonary artery hypertension

  2022cites this paper
• Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

  2022cites this paper
• Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH

  2022cites this paper
• New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis

  2022cites this paper
• Pulmonary Arterial Hypertension Secondary to Drugs and Toxins.

  2021cites this paper
• Pulmonary hypertension: clinical phenotypes and non-invasive risk stratification

  2020cites this paper
• Drug- and toxin-induced pulmonary arterial hypertension: Current state of the literature

  2020cites this paper
• Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome

  2020cites this paper
• New insights into BMP9 signaling in organ fibrosis.

  2020cites this paper
• PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2

  2020cites this paper
• Clinical Differences and Outcomes between Methamphetamine-Associated and Idiopathic Pulmonary Arterial Hypertension in the PHAR.

  2020cites this paper
• Forced Overexpression of Translationally Controlled Tumor Protein ( TCTP / TPT 1 ) Induces a Growth-Dysregulated Phenotype in Endothelial and Smooth Muscle Cells : Role of TCTP Exosomal Export in Paracrine Cell-Cell Signaling Induced by Endothelial Injury

  2019cites this paper
• Pulmonale Hypertonie

  2019cites this paper
• United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

  2019cites this paper
• Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

  2018cites this paper
• Study of the BMPR 2 Gene in Patients with Pulmonary Arterial Hypertension

  2018cites this paper
• OBSOLETE: Pulmonary Hypertension

  2018cites this paper
• The role of Tumour Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in Pulmonary Arterial Hypertension

  2018cites this paper
• Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon

  2018cites this paper
• Patients with Chronic Obstructive Pulmonary Disease (COPD) Travelling to Altitude: Physiological and Clinical Changes and their Prevention

  2018influential citation
• Anorexigen-Associated Pulmonary Arterial Hypertension and the Serotonin Hypothesis: A Story Worth Telling

  2018cites this paper
• Identification of a low frequency missense mutation in MUC6 contributing to pulmonary artery hypertension by whole-exome sequencing

  2018cites this paper
• Bone Morphogenetic Protein Signaling in Pulmonary Arterial Hypertension

  2017cites this paper
• Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques

  2017cites this paper
• Heritable pulmonary hypertension: from bench to bedside

  2017cites this paper
• The role of genetics in pulmonary arterial hypertension

  2017cites this paper
• Identity crisis in pulmonary arterial hypertension

  2017cites this paper
• Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

  2017cites this paper
• Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension. A New Chapter of the Story.

  2017cites this paper
• pleural thickening in a 20-year-old man Prolonged fever, dyspnoea and diffuse

  2017cites this paper
• Genetics of pulmonary hypertension in the clinic

  2017cites this paper
• Drug-Induced Pulmonary Hypertension: The First 50 Years.

  2017cites this paper
• BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

  2016cites this paper
• linical Classification of Pulmonary Hypertension

  2016cites this paper
• The Role of Stem Cells in Vascular Remodeling in CTEPH

  2015cites this paper
• Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

  2015cites this paper
• Pathogenic Mechanisms of Pulmonary Hypertension

  2015cites this paper
• Metabolic Dysfunction in Pulmonary Arterial Hypertension

  2015cites this paper
• Connexin-mediated regulation of the pulmonary vasculature.

  2015cites this paper
• The Genetics of Pulmonary Arterial Hypertension

  2014cites this paper
• Austin and Loyd The Genetics of Pulmonary Arterial Hypertension

  2014cites this paper
• The genetic basis of pulmonary arterial hypertension

  2014cites this paper
• Inhibition of Bone Morphogenic Protein 4 Restores Endothelial Function in db/db Diabetic Mice

  2014cites this paper
• BMPR2 Germline Mutation in Chronic Thromboembolic Pulmonary Hypertension

  2014cites this paper
• Targeted therapies in pulmonary arterial hypertension.

  2014cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2014cites this paper
• Pathology, Pathobiology and Pathophysiology of Pulmonary Arterial Hypertension

  2014cites this paper
• Signal transduction in the development of pulmonary arterial hypertension

  2013cites this paper
• The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

  2013cites this paper
• Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension

  2013cites this paper
• Pediatric pulmonary hypertension.

  2013cites this paper
• Pathogenesis of Pulmonary Hypertension

  2013cites this paper
• Pulmonary arterial hypertension

  2013cites this paper
• Development of strategies for vascular damage repair in Pulmonary Arterial Hypertension

  2013cites this paper
• A Comprehensive Review: The Evolution of Animal Models in Pulmonary Hypertension Research; Are We there Yet?

  2013cites this paper
• Pharmacogenomics of Pulmonary and Respiratory Diseases

  2013cites this paper
• Spontaneously remitted pulmonary arterial hypertension associated with the herbal medicine "bofutsushosan".

  2013cites this paper
• Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia–associated pulmonary hypertension

  2013cites this paper
• The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies

  2013cites this paper
• Pulmonary hypertension: biomarkers.

  2013cites this paper
• Metabolic Remodeling and Mitochondrial Dysfunction in Maladaptive Right Ventricular Hypertrophy Secondary to Pulmonary Arterial hypertension

  2013cites this paper
• Heritable Forms of Pulmonary Arterial Hypertension

  2013cites this paper
• Genetics of pulmonary arterial hypertension.

  2013cites this paper
• Genetics of Pulmonary Arterial Hypertension and the Concept of Heritable Pulmonary Arterial Hypertension

  2012cites this paper
• Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

  2012cites this paper
• Genetics and pharmacogenomics in pulmonary arterial hypertension.

  2012cites this paper
• Missense Mutations of the BMPR 1 B ( ALK 6 ) Gene in Childhood Idiopathic Pulmonary Arterial Hypertension

  2012cites this paper
• [Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].

  2012cites this paper
• Avaliação do ventrículo direito nos pacientes com hipertensão pulmonar

  2012cites this paper
• Hypertension pulmonaire : de la physiopathologie moléculaire aux anomalies hémodynamiques

  2012cites this paper
• A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

  2012cites this paper
• Innovation thérapeutique dans la dysfonction endothéliale associée à l'hypertension artérielle pulmonaire

  2012cites this paper
• Pharmacogenetics of drugs withdrawn from the market.

  2012cites this paper
• Targeting PDGF pathway in pulmonary arterial hypertension

  2012cites this paper
• Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension.

  2012cites this paper
• Waiting in anticipation: the genetics of pulmonary arterial hypertension.

  2012cites this paper
• Pulmonary hypertension associated with benfluorex exposure

  2012cites this paper
• Génétique de l'hypertension artérielle pulmonaire : du fondamental au conseil génétique

  2011cites this paper
• BMPs and their clinical potentials.

  2011cites this paper
• Molecular Genetics of Pulmonary Hypertension

  2011cites this paper
• Anorexigènes et maladies cardiovasculaires : les liaisons dangereuses

  2011cites this paper
• Whistleblowers

  2011cites this paper
• Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.

  2011cites this paper
• Pulmonary Arterial Hypertension Secondary to Anorexigens and Other Drugs and Toxins

  2011cites this paper
• Anorexigènes et maladies cardiovasculaires : les liaisons dangereuses Anorectic drugs and cardiovascular diseases : Les Liaisons dangereuses

  2011cites this paper
• Programmatic change: lung disease research in the era of induced pluripotency.

  2011cites this paper
• Genetics of Familial and Idiopathic Pulmonary Arterial Hypertension

  2011cites this paper
• Contemporary issues in pulmonary hypertension

  2010cites this paper
• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  2010cites this paper
• Study of the BMPR2 gene in patients with pulmonary arterial hypertension

  2010cites this paper
• Genetics of pulmonary arterial hypertension: do the molecular findings have translational value?

  2010cites this paper